Y. Rakké

Most-cited papers

1. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells

   Lucia Campos Carrascosa, A. V. van Beek, Valeska de Ruiter, M. Doukas +18 more

   2020Journal for ImmunoTherapy of Cancer19 citations Open access

   Semantic Scholar

   Save

2. A mortality prediction model for elderly patients with critical limb ischemia.

   J. Roijers, Y. Rakké, C. J. Hopmans, M. G. Buimer +5 more

   2019Journal of Vascular Surgery19 citations Open access

   Semantic Scholar

   Save

3. Incidence and Risk Factors for Delirium in Elderly Patients with Critical Limb Ischaemia.

   J. Roijers, Y. Rakké, C. J. Hopmans, M. G. Buimer +5 more

   2019European Journal of Vascular and Endovascular Surgery16 citations Open access

   Semantic Scholar

   Save

4. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells

   Y. Rakké, Lucia Campos Carrascosa, A. V. van Beek, Valeska de Ruiter +13 more

   2022Cellular and Molecular Gastroenterology and Hepatology13 citations Open access

   Semantic Scholar

   Save

5. Seriously Ill Patients as Living Unspecified Kidney Donors: Rationale and Justification

   Y. Rakké, W. Zuidema, M. Hilhorst, R. Erdman +5 more

   2015Transplantation11 citations Open access

   Semantic Scholar

   Save

6. Camrelizumab—targeting a novel PD-1 epitope to treat hepatocellular carcinoma

   Y. Rakké, D. Sprengers, J. Kwekkeboom, J. Ijzermans

   2020Annals of Translational Medicine6 citations Open access

   Semantic Scholar

   Save

7. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers – how to push the gas after having released the brake

   Y. Rakké, S. Buschow, Jan N. M. Ijzermans, D. Sprengers

   2024Frontiers in Immunology3 citations

   Semantic Scholar

   Save

8. 588 Targeting GITR enhances human tumour-infiltrating T cell functionality in mismatch repair proficient primary colorectal carcinoma and liver metastases

   Y. Rakké, Lucia Campos Carrascosa, A. V. van Beek, Valeska de Ruiter +11 more

   2020Journal for ImmunoTherapy of Cancer2 citations Open access

   Semantic Scholar

   Save

9. What happens to elderly patients on the waiting list for a renal transplantation

   Y. Rakké, M. Laging, J. K. Kal-van Gestel, C. Konijn +3 more

   20142 citations

   Semantic Scholar

   Save

10. FRI-059 Identification and characterization of tumor-reactive CD8 and CD4 T cells in hepatocellular carcinoma

    Luc Magré, Y. Rakké, Rachelle S. van Gemerden, M. Doukas +4 more

    2025Journal of Hepatology0 citations

    Semantic Scholar

    Save

11. Identification of hepatocyte-restricted antigens, epitopes, and T cell receptors to treat recurrent hepatocellular carcinoma after liver transplantation

    Y. Rakké, Dian Kortleve, A. Oostvogels, Robbie J. Luijten +7 more

    2023Journal of Hepatology0 citations

    Semantic Scholar

    Save

12. 1181 Therapeutic vaccines consisting of cancer germline antigen-based synthetic long peptides are immunogenic in human hepatocellular carcinoma patients

    Y. Rakké, Marij Schoenmaekers-Welters, Lisanne Noordam, Sanne Boekestijn +14 more

    2022Regular and Young Investigator Award Abstracts0 citations Open access

    Semantic Scholar

    Save

13. Seriously Ill Patients as Living Unspecified Kidney Donors.: Abstract# A285

    W. Zuidema, Y. Rakké, R. Erdman, E. Massey +4 more

    20140 citations

    Semantic Scholar

    Save